Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA endonuclease activity

POP7 AGO2 AGO4

2.02e-0479293GO:0004521
GeneOntologyMolecularFunctionRNA nuclease activity

POP7 AGO2 AGO4

9.92e-04136293GO:0004540
GeneOntologyMolecularFunctionendonuclease activity

POP7 AGO2 AGO4

9.92e-04136293GO:0004519
GeneOntologyMolecularFunctionRNA endonuclease activity, producing 5'-phosphomonoesters

POP7 AGO2

1.31e-0337292GO:0016891
GeneOntologyMolecularFunctionendonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters

POP7 AGO2

2.03e-0346292GO:0016893
GeneOntologyMolecularFunctionmiRNA binding

AGO2 AGO4

2.20e-0348292GO:0035198
GeneOntologyMolecularFunctionregulatory RNA binding

AGO2 AGO4

3.65e-0362292GO:0061980
GeneOntologyMolecularFunctionnuclease activity

POP7 AGO2 AGO4

4.47e-03231293GO:0004518
GeneOntologyMolecularFunctiondouble-stranded RNA binding

AGO2 AGO4

5.71e-0378292GO:0003725
GeneOntologyMolecularFunctioncollagen binding

CD44 ADAM9

6.15e-0381292GO:0005518
GeneOntologyBiologicalProcesssiRNA-mediated gene silencing by mRNA destabilization

AGO2 AGO4

1.14e-054292GO:0090625
GeneOntologyBiologicalProcesssiRNA-mediated post-transcriptional gene silencing

AGO2 AGO4

1.14e-054292GO:0140766
GeneOntologyBiologicalProcessmacrophage fusion

CD44 ADAM9

5.32e-058292GO:0034238
GeneOntologyBiologicalProcessRNA secondary structure unwinding

AGO2 AGO4

6.83e-059292GO:0010501
GeneOntologyBiologicalProcessRISC complex assembly

AGO2 AGO4

8.53e-0510292GO:0070922
GeneOntologyBiologicalProcesspre-miRNA processing

AGO2 AGO4

2.56e-0417292GO:0031054
GeneOntologyCellularComponentendoribonuclease complex

POP7 AGO2 AGO4

1.81e-0537293GO:1902555
GeneOntologyCellularComponentendonuclease complex

POP7 AGO2 AGO4

2.85e-0543293GO:1905348
GeneOntologyCellularComponentRISC-loading complex

AGO2 AGO4

8.30e-0510292GO:0070578
DomainArgonaute_N

AGO2 AGO4

1.39e-054292IPR032474
DomainArgonaute_Mid_dom

AGO2 AGO4

1.39e-054292IPR032473
DomainArgoL2

AGO2 AGO4

1.39e-054292IPR032472
DomainArgoN

AGO2 AGO4

1.39e-054292PF16486
DomainArgoMid

AGO2 AGO4

1.39e-054292PF16487
DomainArgoL2

AGO2 AGO4

1.39e-054292PF16488
DomainDUF1785

AGO2 AGO4

2.32e-055292SM01163
DomainArgoL1

AGO2 AGO4

3.48e-056292PF08699
DomainArgoL1

AGO2 AGO4

3.48e-056292IPR014811
Domain-

AGO2 AGO4 ESRP1

5.21e-05472933.30.420.10
DomainPIWI

AGO2 AGO4

6.48e-058292PS50822
DomainPiwi

AGO2 AGO4

6.48e-058292IPR003165
DomainPiwi

AGO2 AGO4

6.48e-058292PF02171
DomainPiwi

AGO2 AGO4

6.48e-058292SM00950
DomainPAZ

AGO2 AGO4

8.32e-059292PS50821
DomainPAZ_dom

AGO2 AGO4

8.32e-059292IPR003100
DomainPAZ

AGO2 AGO4

8.32e-059292PF02170
DomainPAZ

AGO2 AGO4

8.32e-059292SM00949
DomainRNaseH-like_dom

AGO2 AGO4 ESRP1

1.65e-0469293IPR012337
DomainP-loop_NTPase

SRL DSEL DNAH8 RHOT1 NLRP5

9.14e-03848295IPR027417
PathwayBIOCARTA_DICER_PATHWAY

AGO2 AGO4

2.32e-055222M22079
PathwayREACTOME_MICRORNA_MIRNA_BIOGENESIS

AGO2 AGO4

3.47e-056222MM14818
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

AGO2 AGO4

3.47e-056222MM15083
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

AGO2 AGO4

4.86e-057222M46421
PathwayREACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS

AGO2 AGO4

6.47e-058222MM15082
PathwayREACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS

AGO2 AGO4

8.31e-059222M27340
PathwayREACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION

AGO2 AGO4

8.31e-059222M27810
PathwayREACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION

AGO2 AGO4

8.31e-059222M46436
PathwayREACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS

AGO2 AGO4

1.04e-0410222M48013
PathwayREACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION

AGO2 AGO4

1.79e-0413222M46434
PathwayREACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY

AGO2 AGO4

3.12e-0417222M27788
PathwayREACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS

AGO2 AGO4

3.91e-0419222M48238
PathwayREACTOME_MICRORNA_MIRNA_BIOGENESIS

AGO2 AGO4

6.82e-0425222M712
PathwayREACTOME_TGFBR3_EXPRESSION

AGO2 AGO4

8.57e-0428222M48253
PathwayREACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION

AGO2 AGO4

1.12e-0332222M48012
PathwayREACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY

AGO2 AGO4

1.12e-0332222M27900
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

AGO2 AGO4

1.27e-0334222M46422
PathwayREACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER

AGO2 AGO4

1.34e-0335222M42525
PathwayREACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX

AGO2 AGO4

1.50e-0337222M29790
PathwayREACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING

AGO2 AGO4

2.41e-0347222M29777
PathwayWP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES

PEX2 SRL CSNK1G2 NECAP1

2.61e-03381224M48063
PathwayREACTOME_GENE_SILENCING_BY_RNA

AGO2 AGO4

2.62e-0349222MM14837
PathwayREACTOME_SIGNALING_BY_TGFBR3

AGO2 AGO4

2.62e-0349222M48250
PathwayREACTOME_ADHERENS_JUNCTIONS_INTERACTIONS

AGO2 AGO4

3.65e-0358222M11980
PathwayREACTOME_CA2_PATHWAY

AGO2 AGO4

4.15e-0362222M27321
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2

AGO2 AGO4

4.29e-0363222M27862
Pubmed

Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing hearts.

AGO2 ANKRD1

6.71e-07229238475992
Pubmed

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

CD44 ESRP1

6.71e-07229222673910
Pubmed

Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.

CD44 ESRP1

2.01e-06329229130517
Pubmed

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

CD44 ESRP1

2.01e-06329227500490
Pubmed

Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins.

AGO2 AGO4

2.01e-06329219946268
Pubmed

Argonaute proteins: potential biomarkers for human colon cancer.

AGO2 AGO4

4.02e-06429220146808
Pubmed

Molecular dissection of human Argonaute proteins by DNA shuffling.

AGO2 AGO4

4.02e-06429223748378
Pubmed

Slicing-independent RISC activation requires the argonaute PAZ domain.

AGO2 AGO4

4.02e-06429222795694
Pubmed

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

AGO2 AGO4

4.02e-06429215260970
Pubmed

The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency.

AGO2 ESRP1

4.02e-06429229074849
Pubmed

ATP-dependent human RISC assembly pathways.

AGO2 AGO4

4.02e-06429219966796
Pubmed

Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.

AGO2 AGO4

4.02e-06429218771919
Pubmed

Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors.

AGO2 AGO4

6.70e-06529212526743
Pubmed

Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells.

AGO2 AGO4

6.70e-06529219393748
Pubmed

The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing.

AGO2 AGO4

6.70e-06529219324964
Pubmed

Involvement of microRNA in AU-rich element-mediated mRNA instability.

AGO2 AGO4

6.70e-06529215766526
Pubmed

Argonaute identity defines the length of mature mammalian microRNAs.

AGO2 AGO4

6.70e-06529222505576
Pubmed

Differential expression of components of the microRNA machinery during mouse organogenesis.

AGO2 AGO4

6.70e-06529216036130
Pubmed

The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

AGO2 AGO4

6.70e-06529212414724
Pubmed

Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development.

AGO2 AGO4

1.41e-05729234907157
Pubmed

Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cells.

CD44 ESRP1

1.41e-05729223299472
Pubmed

Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.

AGO2 AGO4

1.41e-05729219536157
Pubmed

The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins.

AGO2 AGO4

1.41e-05729219383768
Pubmed

Functional dissection of the human TNRC6 (GW182-related) family of proteins.

AGO2 AGO4

1.41e-05729219470757
Pubmed

Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis.

AGO2 AGO4

1.87e-05829219345100
Pubmed

Suppression of microRNA Activity in Kidney Collecting Ducts Induces Partial Loss of Epithelial Phenotype and Renal Fibrosis.

AGO2 AGO4

1.87e-05829229021386
Pubmed

Identification of eight members of the Argonaute family in the human genome.

AGO2 AGO4

2.41e-05929212906857
Pubmed

Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs.

AGO2 AGO4

8.00e-051629220102707
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CCT4 DZANK1 DMXL2 AGO2 NEK9 ADAM9

1.22e-0496329628671696
Pubmed

The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2.

AGO2 AGO4

2.15e-042629219898466
Pubmed

Inactivation of Zeb1 in GRHL2-deficient mouse embryos rescues mid-gestation viability and secondary palate closure.

CD44 ESRP1

2.50e-042829232005677
Pubmed

Cytoplasmic aggregation of DDX1 in developing embryos: Early embryonic lethality associated with Ddx1 knockout.

AGO2 NLRP5

2.69e-042929231330130
Pubmed

Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.

RTN4IP1 SLC25A19 COA7 RHOT1

3.68e-0441329427499296
Pubmed

YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme.

CD44 ANKRD1

4.16e-043629228943241
Pubmed

ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development.

CD44 ESRP1

5.66e-044229229107558
Pubmed

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

CD44 POP7 ADAM9 RHOT1

7.48e-0449929422810586
CytobandEnsembl 112 genes in cytogenetic band chr8p11

ADGRA2 ADAM9

1.95e-03103292chr8p11
GeneFamilyArgonaute/PIWI family

AGO2 AGO4

2.61e-058182408
GeneFamilyAnkyrin repeat domain containing

DZANK1 ANKRD1

2.37e-02242182403
ToppCellLV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper

POP7 TESMIN ANKRD1

6.43e-051202933b77bd0e3630cdd45001cecf5e47660a90ebc92e
ToppCellLV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

POP7 TESMIN ANKRD1

8.15e-05130293a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCellwk_20-22-Hematologic-Myeloid-HSC/ELP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CD44 TESMIN CRHBP

1.62e-041642933c07d8f53511f269540bf032738a4ada35650b18
ToppCellfacs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL CRHBP ANKRD1

1.68e-04166293c43aec09578975df8984886993d15b42a10190c8
ToppCellfacs-Heart-LA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL CRHBP ANKRD1

1.68e-04166293829a8998ce68739a58202851afd73e049ab0f84f
ToppCellfacs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 ANKRD1 ESRP1

1.68e-0416629311b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCellfacs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 ANKRD1 ESRP1

1.68e-04166293fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCellfacs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL ST8SIA5 ANKRD1

1.86e-04172293bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCellfacs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL ST8SIA5 ANKRD1

1.86e-04172293ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCelldroplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 SRL ESRP1

1.86e-0417229330916a902c151907745756d14327e24adc34afef
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CD44 DMXL2 TESMIN

1.93e-0417429365147b0f8c2ccadd5685430d31081520c157536a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SRL ADGRA2 DNAH8

1.96e-04175293316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SRL ADGRA2 DNAH8

1.96e-04175293a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSEL CSNK1G2 ESRP1

2.03e-04177293164ffbbf798defa3728197deb1a14b661490e525
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARFGEF3 DMXL2 TESMIN

2.03e-04177293e1e45956887371b1c18f1eb479dd930031497520
ToppCellfacs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 AGO2 ESRP1

2.24e-04183293b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e
ToppCellPCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 ANKRD1 ESRP1

2.27e-04184293fa4915b0498f3069fd5ef497286445528f75187e
ToppCelldroplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL COA7 ESRP1

2.38e-041872935fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCelldroplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL COA7 ESRP1

2.38e-04187293766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCelldroplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRL COA7 ESRP1

2.38e-04187293f49d06600060deeb2fc1b1da5b93496535f20104
ToppCellPCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 TESMIN ESRP1

2.46e-04189293c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCellPCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 CRHBP ESRP1

2.54e-0419129372dbd2e0fabfca8d6f604df35277d3574739a0b3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 AGO2 ADAM9

2.58e-041922938b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCellPCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TESMIN ANKRD1 ESRP1

2.58e-041922938898332387e5d746feb346ce1dabd6b2218fc6e5
ToppCellPCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 CRHBP ESRP1

2.58e-04192293c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5
ToppCellControl-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

CD44 DMXL2 ADAM9

2.62e-041932932a6d531abd34df20941cf3dac4fdfb1621a1bde6
ToppCellControl-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

CD44 DMXL2 ADAM9

2.66e-04194293c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCellCOVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type

CD44 ARFGEF3 ESRP1

2.74e-0419629304f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell10x5'-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue

CD44 DMXL2 ADAM9

2.74e-04196293fede2c605f7581ce2ea7a284cffffa1a3970d811
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD44 DMXL2 ADAM9

2.74e-041962935bcb57c57d5da0440220a1133a96aa89407bd871
ToppCellMegakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

CD44 CCT4 CRHBP

2.74e-04196293f90e7fe3a7b2fff30d01a25cc500876861c2e4f1
ToppCellControl-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class

CD44 DMXL2 ADAM9

2.74e-04196293e2c2a30fa3ee3034fbde5335be169e880dde622d
ToppCellMegakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

CD44 CCT4 CRHBP

2.74e-041962934e97010185fa9392da8f69e7b2a7395bf063f8ff
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DSEL SLC25A19 ANKRD1

2.82e-041982935a85c286f79cde5811d2595a3397c6fb7685adee
ToppCellIPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

CD44 DMXL2 ADAM9

2.86e-041992933c2b362d5e824e1a04830e70352f8818de984174
ToppCellfacs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 CCT4 GPBP1

2.86e-041992938d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCellCOPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

CD44 DMXL2 ADAM9

2.86e-041992931cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCellmoderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 DMXL2 ADAM9

2.86e-041992933895e367a33ac0316f96a64c07574de99684f4b7
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD44 CCT4 GPBP1

2.86e-04199293f3cc3cda38f78d1d12d865df339d93c5fecf19f2
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD44 CCT4 GPBP1

2.86e-04199293c3c73c9404a73133bfad1f9ced292f5e508ef767
ToppCellTracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 ADAM9 ESRP1

2.90e-04200293c450a15e21fa72d071ed6e3b9f22de557a0f3cea
DiseaseCocaine-Related Disorders

AGO2 DNAH8 CRHBP

2.06e-04117293C0236736
DiseaseCocaine Abuse

AGO2 DNAH8 CRHBP

2.62e-04127293C0009171
DiseaseCocaine Dependence

AGO2 DNAH8 CRHBP

3.42e-04139293C0600427
Diseasehypothyroidism

CD44 POP7 AGO2

2.68e-03284293EFO_0004705

Protein segments in the cluster

PeptideGeneStartEntry
CGKNRLKALRGGAAG

ADGRA2

1196

Q96PE1
GGNLDVLKLLLNKGA

ANKRD1

196

Q15327
ILNQKILGCQKDGSG

DMXL2

1771

Q8TDJ6
TLSNLCLKINAKLGG

AGO4

551

Q9HCK5
CLKINAKLGGINNVL

AGO4

556

Q9HCK5
SNLCLKINVKLGGVN

AGO2

561

Q9UKV8
KGLNIAKGGAALCLN

ESRP1

246

Q6NXG1
GKVLACGLNEFNKLG

NEK9

551

Q8TD19
GLRKNGILKNGLICD

GPBP1

426

Q86WP2
KIGCGNFGELRLGKN

CSNK1G2

51

P78368
VKNCGKSGVLQALLG

RHOT1

426

Q8IXI2
KQCVNFVIGLLKLGG

PEX2

136

P28328
QALIKGGAALDLKAC

DNAH8

3781

Q96JB1
QKNSVLARLGLKACG

NLRP5

1091

P59047
KAQLARCQKLLDGGA

POP7

46

O75817
CGQKKKLVINSGNGA

CD44

676

P16070
NGLQLKKSSAGCEGI

CRHBP

226

P24387
KCLLKKVSGIGGAAN

ARFGEF3

1791

Q5TH69
EKLTLNKGGNCLLNI

ADAM9

391

Q13443
LLGCNASIQKKNAGG

DZANK1

696

Q9NVP4
LFKIEGGKGKCNLNS

DSEL

1061

Q8IZU8
LGADCKGQVKAKLAG

TESMIN

71

Q9Y4I5
GGLNDKNCTGKRVLI

RTN4IP1

196

Q8WWV3
FKKCAVVGNGGILKN

ST8SIA5

161

O15466
NLNGSGKLLKITGCA

CCT4

366

P50991
GKGGLTQDLKAAARC

COA7

81

Q96BR5
LGLGKNPGALNCDKT

SRL

446

Q86TD4
GKKNENLQNLLCGSG

SLC25A19

211

Q9HC21
SKNGGIYLLANQKGC

NADSYN1

221

Q6IA69
LCIGNITNKKGGASK

NECAP1

161

Q8NC96